FDA advisers endorse Pfizer and Moderna vaccines for children younger than 5

FDA advisers endorse Pfizer and Moderna vaccines for children younger than 5

The U.S. has taken another step toward making children younger than 5 years old eligible for COVID vaccinations. Advisers to the FDA on Wednesday unanimously voted to recommend authorization of Pfizer and Moderna’s vaccines for kids aged 6 months to under 5 years. It’s a critical move for the youngest Americans, who until now have not been able to be inoculated. Meg Oliver reports.